Home › Juvenile Arthritis › Florida
Juvenile Arthritis clinical trials in Florida
4 studies for Juvenile Arthritis are looking for participants at sites in Florida.
Cities in Florida
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
- University of Florida, Gainesville
RecruitingPhase 1
Ages 2 to 17 · All sexes · Updated Sep 28, 2026 · NCT06751238Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
- University of Florida, Gainesville
RecruitingPhase 3
Ages 2 to 21 · All sexes · Updated Sep 25, 2026 · NCT06654882A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Joe Dimaggio Children's Hospital Hollywood /ID# 260634, Hollywood
- All X Ray Diagnostic Services Corp /ID# 278523, Miami
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 1, 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- University of Florida - Shand's Children's Hospital, Gainesville
- Nemours Children's Hospital, Orlando
- Johns Hopkins All Children's Hospital, St. Petersburg
RecruitingObservational study
Up to age 21 · All sexes · Updated Aug 27, 2026 · NCT02418442From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.